The global cell analysis market is projected to reach USD 33.9 Billion by 2028 from USD 20.2 Billion in 2023, at a CAGR of 10.9% during the forecast period. Increase in demand of cell-based assays in drug discovery and development applications is expected to positively impact the market growth. Cell-based assays have shown high biological relevance when compared with biochemical assays, suitable to enhance the process of drug discovery and developmen. Prediction of complexities associated with therapeutic response of a biological system is set to minimze the time of product-to-market duration, particularly for novel pharmaceutical candidates such as acell and gene therapies.
Cell analysis market is fragmented in nature with prominent companies building their portfolio around different cell analysis techniques namely, PCR, flow cytometry, and microarray among Prominent players in the global cell analysis market are Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).
To know about the assumptions considered for the study download the pdf brochure
THERMO FISHER SCIENTIFIC (US)
Thermo Fisher Scientific is one of the leading players in the cell analysis market. Its leading position can be attributed to its strong brand recognition and extensive product portfolio in this market. The company has a strong foothold in the market, owing to a strong sales and distribution network. It adopts organic and inorganic growth strategies such as product launches, acquisitions, and expansions to maintain its position in the cell analysis market. In the past three years, the company has launched more than ten products in the cell analysis market, which has helped it strengthen its product offerings.
Danaher offers a wide range of instruments and consumables used in cell-based assays through its Life Science business subsidiaries, Molecular Devices, Beckman Coulter, and Cytiva. Danaher has a strong foothold in the cell analysis market, owing to its strong sales and distribution network. The company’s growth strategy relies on its Life Sciences business segment since it focuses on technical innovations for improved production efficiency. In line with this, Danaher has launched more than ten products in the past three years. The company also invests in incorporating cutting-edge technologies into its Life Sciences business.
BECTON, DICKINSON AND COMPANY (US)
BD is one of the leading manufacturers of cell analysis products. The company specializes in the development and manufacturing of single-cell sorters, cell analyzers, and kits that are used in cell analysis procedures. BD’s leading position can be attributed to its robust product portfolio and strong geographical presence. In order to improve the efficiency of its cell analysis activities, BD focuses on developing new products, which is evident from its recent product launches. The company’s products are manufactured and sold across the globe. Its products are also marketed in the US and internationally through direct sales and independent distribution channels.
Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE